Agrupación Estratéxica en Xestión e Produción sustentable de Biorrecursos (BioReDes)
Agrupación estratéxica de I+D+i
![Foto de Agrupación Estratéxica en Xestión e Produción sustentable de Biorrecursos (BioReDes)](/img/noimage.png)
![Foto de Hospital Universitario de Basurto](/img/noimage_org.png)
Hospital Universitario de Basurto
Bilbao, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario de Basurto (21)
2023
-
Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions
Journal of Clinical Virology, Vol. 167
-
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort
International Journal of Infectious Diseases, Vol. 137, pp. 134-143
-
Susceptibility to hepatitis B virus infection in adults living in Spain
Liver International, Vol. 43, Núm. 5, pp. 1015-1020
-
The slowdown of new infections by human retroviruses has reached a plateau in Spain
Journal of Medical Virology, Vol. 95, Núm. 5
2022
-
Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria
Open Forum Infectious Diseases, Vol. 9, Núm. 9
2019
-
Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain
Journal of Antimicrobial Chemotherapy, Vol. 74, Núm. 5, pp. 1357-1362
-
Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain
Open Forum Infectious Diseases, Vol. 6, Núm. 2
2017
-
Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2083-2088
-
Glycemia in Acute Stroke II study: a call to improve post-stroke hyperglycemia management in clinical practice
European Journal of Neurology, Vol. 24, Núm. 9, pp. 1091-1098
-
HIV type 2 epidemic in Spain: Challenges and missing opportunities
AIDS, Vol. 31, Núm. 10, pp. 1353-1364
-
Human T-lymphotropic virus type 1 infection and disease in Spain
AIDS, Vol. 31, Núm. 12, pp. 1653-1663
2014
-
HIV-2 and HTLV-1 infections in Spain, a non-endemic region
AIDS Reviews, Vol. 16, Núm. 3, pp. 152-159
-
HIV-2 viral tropism influences CD4+ T cell count regardless of viral load
Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 8, pp. 2191-2194
2010
-
Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in Spain
Journal of Clinical Microbiology, Vol. 48, Núm. 11, pp. 4200-4206
-
Zonisamida en el tratamiento preventivo de la migraña refractaria
Revista de Neurologia, Vol. 50, Núm. 3, pp. 129-132
2008
-
Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277
2007
-
Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)
Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229
2002
-
Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin [3]
Journal of Antimicrobial Chemotherapy
1999
-
Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: Results of a 1-year (1996-1997) multicenter surveillance study
Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 1, pp. 178-180
-
Estudio multicentrico de resistencias en enterococos. Papel de la teicoplanina
Revista Espanola de Quimioterapia, Vol. 12, Núm. 3, pp. 237-243